Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Businessweek Archives

Value Maven


Personal Business: FUND WATCH

VALUE MAVEN

Besides running the $12.3 billion T. Rowe Price Equity Income Fund, Brian Rogers manages the firm's $509 million Value Fund. Value has returned an annual average 30.8% since its 1994 debut by betting on turnarounds. He chatted with BUSINESS WEEK Senior Writer Robert Barker:

Q: What have you bought lately?

A: U.S. Surgical. The stock fell from about 45 to 25 over the past 18 months; it's about 29 now. The company has a decent balance sheet and a relatively low price-earnings ratio, given that it's in health-care products.

Q: What else?

A: Inco (16), a huge nickel producer. The company's market value is less than what it paid for a big property, Voisey's Bay, in Canada. Obviously, Inco is a bet on nickel prices getting better some day, but in our view, it's an asset play.

Q: What will catch your eye next?

A: I'm most intrigued with figuring out what to do about energy. That's a sector where the Value Fund has not had substantial investments, and the stocks have been killed.

Q: You mean exploration and production companies, or oil-service outfits?

A: Companies with assets in the ground. With the price of the commodity under pressure, the service companies don't look as inexpensive as the companies that actually own the stuff.EDITED BY AMY DUNKIN


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus